Zensar Technologies Limited (ZENSARTECH) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 24, 2026 3 min read

Zensar Technologies enters Q1 FY27 with a focus on scaling its record-high order book following a mega deal win in the previous quarter. Investors will be looking for early revenue contribution from this deal and management's ability to maintain margins within the 14%–16% band despite transition cost headwinds.

Quick Details

Results date	July 29, 2026
Quarter	Q1 FY 2026-2027
Previous quarter revenue	$158.4 M
Previous quarter PAT	14.4% (PAT margin)
Market cap	Rs. 11,243.57 Cr
CMP	Rs. 494.15

Zensar Technologies Limited Q1 Results Date and Time

The board meeting is scheduled for 2026-07-29 to consider and approve the Q1 FY27 unaudited financial results.

The company held its Q4 FY26 earnings call on 2026-04-24; the audio recording is available on the company website.

What to expect from Zensar Technologies Limited's Q1 FY27 results

Management has provided guidance that Q1 FY27 will see no sequential revenue degrowth compared to the Q4 FY26 base of $158.4 M. The revenue trajectory is expected to be supported by the initial ramp-up of the mega deal secured in Q4 FY26, which drove the order book to $401.8 M. While the TMT vertical continues to face structural headwinds with no growth budgeted for the top client in FY27, management expects growth in BFSI and MCS segments to provide a partial offset. EBITDA margins are expected to remain within the 14%–16% band, though they will face a 0.5%–0.6% transition cost headwind related to the mega deal in H1 FY27. Reported INR figures may benefit from the weaker rupee, which traded at record lows during the quarter compared to the year-ago period.

Key Things To Watch

Performance vs Guidance Tracking: Tracking management's stated goals for the fiscal year.

Revenue growth — No degrowth in Q1 FY27 vs $158.4 M — Monitoring actuals
EBITDA margin — 14%–16% band — Monitoring Q1 landing
Transition costs — 0.5%–0.6% impact in Q1 & Q2 — Monitoring H1 margin pressure
Order intake — $180–$200 M standard run-rate — Monitoring Q1 intake

Mega deal execution: Monitoring the ramp-up of the Q4 FY26 mega deal win.

Revenue ramp — Initial contribution expected in Q1 FY27
Full-fledged revenue — Expected by Q3 FY27
Execution risk — Management noted FY27 performance is contingent on this deal

Operating metric trajectory: Key segment and efficiency trends.

TMT vertical — Persistent decline due to client in-sourcing; monitor for stabilisation
Attrition — 9.8% in Q4 FY26; monitor for any spike in Q1
Offshore mix — Continued shift towards offshore delivery as a margin tailwind

Frequently Asked Questions

What is the expected revenue impact of the mega deal in Q1?

Management has stated that the revenue ramp for the mega deal begins in Q1 FY27, with the deal expected to reach full-fledged revenue contribution by Q3 FY27. They have declined to provide specific dollar-value revenue projections for the deal ramp.

Is Zensar's TMT vertical showing signs of recovery?

The TMT vertical has experienced persistent quarterly declines due to client in-sourcing and OpEx rationalisation for AI CapEx. Management has explicitly budgeted for no growth in the top TMT client account for FY27.

How does the company plan to manage margin pressure from the mega deal?

Management anticipates a 0.5%–0.6% margin headwind in H1 FY27 due to upfront transition costs for the mega deal. They intend to offset this through offshore shift, utilisation gains, and cost control initiatives to remain within the 14%–16% EBITDA margin band.